This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
210 Broadway Suite 201
Cambridge, Massachusetts 02139
Founded in 2000 as a spin-off from the University of T?bingen in Germany, CureVac is a technology leader in the development of drugs that are based on the molecule Messenger RNA (mRNA). The fully integrated biopharmaceutical company has more than 15 years ... more
Research Assistant and Author
Dr. Cynthia Meyer, Counseling Skills
Waukesha Family Ymca
MBA Fellow, Executive Ass. To Chief Executive Officer
Advisory Board Member
Europe Unlimited S.A
January 2013-May 2014 Active Member, Secretary 2013-2014 School Year
Family Social Sciences Round Table
Danube University of Krems
University of Tübingen
curevac.de: Management Board
This discovery led to a new fundamental understanding of the potential of RNA to treat diseases and to generate prophylactic immunity.
curevac.de: CureVac presents clinical results of a Phase I/IIa trial in non-small cell lung cancer (NSCLC)
Serra Ventures LLC
Budget Right Kitchens LTD
P.J. Hoerr , Inc.
Phelps County Regional Medical Center